Prospective Diabetes Registry of Patients With Type 2 Diabetes Mellitus on SGLT 2 Inhibitor Therapy in Singapore

Trial Identifier:	D1843R00258
Sponsor:	AstraZeneca
NCTID::	NCT02578563
Start Date:	February 2016
Primary Completion Date:	December 2018
Study Completion Date:	December 2018
Condition:	Endocrine - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Singapore, Singapore	Singapore, Singapore

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.